Novel Delivery Method of Insulin Gene to Combat Juvenile Diabetes Developed
A safer method to deliver the insulin gene to diabetes patients using ...Type 1 or juvenile diabetes is caused by autoimmune destruction ...Recreating appropriately regulated internal insulin secretion in...Dr. Anthony Cheung and his colleagues at enGene Inc. Vancouver...They intend to achieve this by inducing specific cells of the gu...
A safer method to deliver the insulin gene to diabetes patients using nanoparticles, was presented today at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT) in Seattle.
Type 1 or juvenile diabetes is caused by autoimmune destruction of the insulin producing pancreatic -cells. As a result of the loss of insulin, blood sugar levels rise too high, causing damage to fine blood vessels and nerve endings leading to debilitating symptoms. As a result patients become dependent upon daily insulin injections to survive. However, it is virtually impossible to match the sugar content of each meal with the optimal dose of insulin the cumulative mistakes severely reduce both the quality and length of life.
Recreating appropriately regulated internal insulin secretion in surrogate cells (i.e. non--cells) in individuals with diabetes is an attractive approach to cure this disease. A major hurdle with this approach has been replicating automatic insulin secretion that is tuned to the bodys requirements.
Dr. Anthony Cheung and his colleagues at enGene, Inc., Vancouver, aim to develop an approach to restore the meal-responsive insulin production and release capability in individuals with diabetes, thereby eliminating the need for insulin injections while also improving control of blood sugar levels.
They intend to achieve this by inducing specific cells of the gut to take over production of insulin. The team previously reported that gut K-cells can be induced with the insulin gene to produce insulin in response to meal ingestion in a pattern comparable to normal insulin production from the pancreas.
In order to translate this technology to clinical use, the team developed a novel method to deliver the insulin gene to the target K-cells in the gut using nanoparticles. The nanoparticles contain a component called chitosan that provides protection to the insulin gene while in the gut as well as '"/>
(Date:11/10/2009)... BoxTone(R), the expert in mobile user manage...ite to manage, track and control enterprise smartp...rating system. The announcement follows last month... included new support for other ActiveSync-attache...e and Windows Mobile. , C...
(Date:11/10/2009)... Using an ultrasonic cleaner is faster, safer...dical instruments used in healthcare facilities. I...d lower costs through reuse of instruments are add... South Orange, NJ (PRWEB) November 10,... of medical instruments is a critical step in prev...
(Date:11/10/2009)... It is now possible to achieve exceptionally ...osed of hard materials such as ceramics, carbide a...th the new Diamond Flex-Hone® honing tool fr... Los Angeles (PRWEB) November 10, 2009 -- Us...bedded to the ends of flexible filaments, the Diam...
(Date:11/10/2009)... Carrington Nuamah, P.C., a Seattle law firm ...n and estate law, has unveiled a new website. Res... learn more about the firm at www.carringtonnuama...xis Nexis) November 10, 2009 -- Seattle Law Firm C...at www.carringtonnuamah.com . Lawyers Andrew Car...
(Date:11/10/2009)...versity Rollins School of Public Health researcher... American Public Health Association,s annual meeti...d compliance with national recommendations that a ...utes of their arrival to the Emergency Department ...gs from Emory scientists are highlighted below. ,...
... are of the opinion that the Police have become th... inadequacy of prevalent services and support mech...mment follows close on the heels of an incident, w...the frontline of mental health services," Mr Cheve...
...cil of Medical Research has announced the installa...ies by ICMR in Chennai// , New Delhi, Kolkata and ...
An international consultancy firm will be in ...ancial year. A centre of this type has already bee...
...at 6.5 billion and will touch the seven billion m... Time, reported the science portal Live Science.
...ulation every second, the world will be home to se...orld population hit the six billion mark in June 1...
... after announcement of Bird Flu in India .In Gujar...n wiped out. In Utchal taluka of Surat 90,000 c...retary of the Gujarat Broiler Farmers' Association...poultry products across the state except a small p...
...has completely changed. Chinese are experimenting ... (LAT). In this one can life the life of a married...partner does not desires to stay together and that... if one of them refuses, the other would not force...
... foods in the cereal category as they provide fibr...rt of health-conscious consumers. So there is news...luble oat fiber called beta-glucan in their diets.... can help lower blood levels of so-called "bad" ch...
(Date:11/9/2009)... N.Y., Nov. 9 /PRNewswire/ -- On Sept. 11, 2001,...her rescue workers came together to save as many l...hter Brian McCauley was one of those 9/11 first re... ,, Only in his late 30s, McCauley was diagnose...d extensive chemotherapy treatments, leaving him c...
(Date:11/9/2009)... Nov. 9 Women,s sexual health comp...ame to Viveve as it prepares for a 2010 launch of ...s. ,, "Viveve is a name that we believe capture...al health," said Kerry Pope, Viveve,s president an...pose of helping women restore their sense of fulfi...
(Date:11/9/2009).... 9 Boston Scientific Co... of its COGNIS® cardiac resynchronization the...ntable cardioverter defibrillator (ICD) in Japan. ...try of Health, Labor and Welfare (MHLW) in August ... COGNIS and TELIGEN are the result of a multi-year...
...O Annual Meeting Will Further Demonstrate, the S...iple Myeloma -, CAMBRIDGE, Mass., May 16 Millenn...oday announced that new data from VELCADE,clinical...American Society,of Clinical Oncology (ASCO) Annua...008. The data will highlight the significant effic...
...harmaceuticals,Corp. (Nasdaq: MEMY ) today announ... at its R&D Day meeting with the investment commun...M 1414, its lead PDE4 inhibitor,demonstrating the ...e,Company has nominated MEM 68626 as the lead deve...m, and separately confirmed its 2008 development,g...